Skip to main content
To KTH's start page

Publications

Last 50 publications of the institution

[1]
Dahl, L., Bendes, A., Bueno Alvez, M., Albrecht, V., Aghelpasand, H., Björkander, S. ... Schwenk, J. M. (2026). Exploration of immune phenotypes in self-sampling citizens. iScience, 29(2).
[2]
Shi, Z., Ren, H., Lin, C., Li, F., Wu, M., Yang, F. ... Zhong, H. (2026). Tissue-resident microbiota impacts colorectal cancer progression and prognosis. Nature Communications, 17(1).
[3]
Bertilsson, F., Hikmet, F., Hansen, J. N., Uhlén, M., Méar, L. & Lindskog, C. (2026). A High-Resolution Subcellular Map of Proteins in Cells with Motile Cilia. Journal of Proteome Research, 25(1), 231-243.
[4]
Jin, S., Cenier, A., Wetzel, D., Arefaine, B., Moreno-Gonzalez, M., Stamouli, M. ... Schirmer, M. (2026). Microbial collagenase activity is linked to oral–gut translocation in advanced chronic liver disease. Nature Microbiology, 11(1), 211-227.
[5]
Ornago, A. M., Gregorio, C., Triolo, F., Moore, A. Z., Marengoni, A., Beridze, G. ... Vetrano, D. L. (2026). Shared and specific blood biomarkers for multimorbidity. Nature Medicine.
[6]
Chakaroun, R. M., Pradhan, M., Björnson, E., Arvidsson, D., Fridolfsson, J., Gummesson, A. ... Bäckhed, F. (2026). Multi-omic definition of metabolic obesity through adipose tissue–microbiome interactions. Nature Medicine, 32(1), 113-125.
[7]
Bendes, A. (2026). Applications of multiplexed immunoassays for precision medicine (Doctoral thesis , KTH Royal Institute of Technology, Stockholm, TRITA-CBH-FOU 2026:3). Retrieved from https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-375451.
[8]
Pohjanen, E. (2026). Spatial proteome mapping of specialized subcellular structures in human cells (Doctoral thesis , KTH Royal Institute of Technology, TRITA-CBH-FOU 2026:2). Retrieved from https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-375190.
[9]
Karapapa, P., Mondal, S., Zeglio, E. & Das, B. (2026). From CO2 to C1 Liquid Fuels : Molecular Electrochemical Production of Formic Acid and Methanol. Angewandte Chemie International Edition, 65(2).
[10]
Zamproni, L. N., Gökçe, B., Gram, M., Holliday, C., Sendemir, A., Porcionatto, M. A. & Herland, A. (2026). Subventricular Zone-on-a-Chip : A Model to Study Neurogenesis Disruption in Neonatal Intraventricular Hemorrhage. Advanced Science, 13(3).
[11]
Nasiri, R., Madadelahi, M., Nikmaneshi, M. R., Gokce, B., Bijarchi, M. A., Shah, S. ... Herland, A. (2026). Engineering biomimetic tissue barrier models on chips : From design and fabrication to applications in disease modeling and drug screening. Biomaterials, 327.
[12]
Zhu, W., Fung, K., Dhami, P., Sharpe, P., Krivanek, J., Nibali, L. ... Neves, V. C.M. (2026). Characterising the Periodontal Granulation Tissue Using scRNAseq. Journal of Clinical Periodontology, 53(2), 308-320.
[13]
Nasiri, R., Guagliano, G., Van Gastel, D., Sanei, R., Madadelahi, M., Tanriverdi, S. ... Herland, A. (2026). Electrochemical dual-sensing of lactate and glucose using NiO nanoparticles with cross-sensitivity calibration. Talanta : The International Journal of Pure and Applied Analytical Chemistry, 297.
[14]
Rosberg, E. (2025). Building Nanodisc-Based Models to Investigate CIP4 and I-BAR Function on Membranes. .
[15]
Rodrigues, G. R., Fornasier, M., Caselli, L., Malmsten, M., Sparr, E., Jonsson, P. & Franco, O. L. (2025). A Bioinspired Mastoparan Exhibits Concentration-Dependent Anti-Bacterial Activity via Membrane Disruption. ACS Applied Materials and Interfaces.
[16]
Valletta, M., Vetrano, D. L., Gregorio, C., Rizzuto, D., Winblad, B., Canevelli, M. ... Grande, G. (2025). Blood biomarkers of Alzheimer’s disease and progression across different stages of cognitive decline in the community. Nature Communications, 16(1).
[17]
Ekelund, H. (2025). Analysis of cross-reactive T-cell responses in persons with multiple sclerosis. .
[18]
Rinne, S. S., Yin, W., Li, R., Ding, H., Mestre Borras, A., Mahmod, C. ... Gräslund, T. (2025). Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents. ACS Pharmacology & Translational Science, 8(11), 3872-3885.
[19]
Al-Wassiti, G. (2025). Characterization of a Novel Ligand Recognized by Human Neutrophil Expressed G Protein-Coupled Receptors. .
[20]
Hoffmann, U. A., Schuppe, A. Z., Knave, A., Sporre, E., Brismar, H., Englund, E. ... Hudson, E. P. (2025). A Cyanobacterial Screening Platform for Rubisco Mutant Variants. ACS Synthetic Biology, 14(7), 2619-2633.
[21]
Visentin, C., Rizzi, G., Yin, W., Hotot, M., Roy, D., Gräslund, T. ... Ricagno, S. (2025). Affibodies as valuable tool to prevent β2m aggregation under lysosomal-like conditions (vol 20, 67, 2025). Biology Direct, 20(1).
[22]
Li, M., Kim, W., Jin, H., Yang, H., Kong, X., Song, X. ... Mardinoglu, A. (2025). Anticancer effects and mechanisms of Pulsatilla chinensis, Bupleurum chinense and Polyporus umbellatus on human lung carcinoma and hepatoma cells. Computational and Structural Biotechnology Journal, 27, 3066-3078.
[23]
Cai, X., Geyer, P. E., Perez-Riverol, Y., Omenn, G. S., Dong, L., Winkler, R. ... Guo, T. (2025). A standardized framework for circulating blood proteomics. Nature Genetics, 57(10), 2371-2380.
[24]
Domeij, E., Erson, L., Lagervall, R., Lindström, H., Weigelt, R., Werkmäster, J. (2025). Cell Cycle Synchronization and MolecularAnalysis of Stress Responses in Mammalian Cells. .
[25]
Kumlin, P., Flacke Lidberg, T., Törnwall, A., Zabalawi, Y.-A. (2025). Analysis of single-cell data to study the effects of heat shock and Imatinib on human K562-cells. .
[26]
Howey, R., Hong, M.-G., Schwenk, J. M., Cordell, H. J. & et al., (2025). Bayesian network imputation methods applied to multi-omics data identify putative causal relationships in a type 2 diabetes dataset containing incomplete data: An IMI DIRECT Study. PLOS Genetics, 21(7).
[27]
Nilvebrant, J., Moro, C. F., Papalanis, E., Novin, M. O., Ding, H., Li, R. ... Nygren, P.-Å. (2025). An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo. Translational Oncology, 61.
[28]
Ornago, A. M., Pinardi, E., Grande, G., Valletta, M., Calderon-Larranaga, A., Andersson, S. ... Vetrano, D. L. (2025). Blood biomarkers of Alzheimer's disease and 12-year muscle strength trajectories in community-dwelling older adults : a cohort study. LANCET HEALTHY LONGEVITY, 6(5).
[29]
Munsch, G., Mohapatra, A. K., van Hylckama Vlieg, A., Kleber, M. E., Martinez-Perez, A., Le, N. Q. ... Morange, P. E. (2025). A multiomics approach reveals novel regulators of plasma factor V levels: highlight on CLEC4M as a clearance receptor. Blood, 146(5), 628-637.
[30]
Källén, A., Taebnia, N., Widhe, M., Lauschke, V. M. & Hedhammar, M. (2025). 3D Culture in Functionalized FN-Silk Networks Facilitate Proliferation, Differentiation and Phenotypic Stability of Mature Human Primary Cells and Stem Cells. Biotechnology and Bioengineering, 122(9), 2522-2534.
[31]
Baune, B. T., Nilsson, P., Ziller, M. J. & et al., (2025). A stratified treatment algorithm in psychiatry : a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe. European Archives of Psychiatry and Clinical Neuroscience, 275(5), 1453-1464.
[32]
Giang, K. A., Nilvebrant, J., Liu, H., Káradóttir, H., Diao, Y., Svensson Gelius, S. & Nygren, P.-Å. (2025). An Anti-BCMA Affibody Affinity Protein for Therapeutic and Diagnostic Use in Multiple Myeloma. International Journal of Molecular Sciences, 26(11).
[33]
Shi, M., Shi, M., Karlsson, M., Alvez, M. B., Jin, H., Yuan, M. ... et al., (2025). A resource for whole-body gene expression map of human tissues based on integration of single cell and bulk transcriptomics. Genome Biology, 26(1).
[34]
Cristina, V., Giulia, R., Yin, W., Mathilde, H., Dipambita, R., Gräslund, T. ... Stefano, R. (2025). Affibodies as valuable tool to prevent β2m aggregation under lysosomal-like conditions. Biology Direct, 20(1).
[35]
Rönning, S., Thorell, H., Malm, M. & Rockberg, J. (2025). Automated plasmid purification can reducemanual labour and increase titres in AAV production. Human Gene Therapy, 36(3-4), E179-E180.
[36]
Matty, K. (2025). Benchmarking OPM-MEG using Auditory Evoked Responses. .
[37]
Proietti Anastasi, A. (2025). An investigation of regulatory mutations in clinical context. .
[38]
Mortensen, A. C. L., Hofström, C., Persson, H., Dahllund, L., Frejd, F. Y. & Nestor, M. (2025). Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy. Nuclear Medicine and Biology, 144.
[39]
Hambardzumyan, K., Hamsten, C., Lourido, L., Saevarsdottir, S., Nilsson, P., van Vollenhoven, R. F. ... Idborg, H. (2025). Association of matrix metalloproteinase 7 and the alpha-chain of fibrinogen at baseline with response to methotrexate at 3 months in patients with early rheumatoid arthritis. BMC Rheumatology, 9(1).
[40]
Bayati, S., Nazeer, J., Ng, J., George, A. M., Hayes, M., Little, M. A. ... Pin, E. (2025). Autoantibodies towards HFE and SYT5 in anti-neutrophil cytoplasm antibody-associated vasculitis relapse. Rheumatology, 64(5), 3142-3150.
[41]
Karlsson, A., Sporre, E., Strandberg, L., Tóth, S. Z. & Hudson, E. P. (2025). Assessing Metabolite Interactions With Chloroplastic Proteins via the PISA Assay. Bio-protocol, 15(9).
[42]
Zimmermann, I., Dölle, M., Friberg, O., Atallah, E., Eilts, F., Chotteau, V. ... Berensmeier, S. (2025). Calcium-dependent magnetic separation: A novel approach for the integrated processing of high-quality mAbs. Separation and Purification Technology, 371.
[43]
Sadler, C. J., Creamer, A., Giang, K. A., Darmawan, K. K., Shamsabadi, A., Richards, D. A. ... Stevens, M. M. (2025). Adding a Twist to Lateral Flow Immunoassays : A Direct Replacement of Antibodies with Helical Affibodies, from Selection to Application. Journal of the American Chemical Society, 147(14), 11925-11940.
[44]
Grande, G., Valletta, M., Rizzuto, D., Xia, X., Qiu, C., Orsini, N. ... Vetrano, D. L. (2025). Blood-based biomarkers of Alzheimer's disease and incident dementia in the community. Nature Medicine, 31(6), 2027-2035.
[45]
Westerberg, C., Mestre Borras, A., Ståhl, S. & Löfblom, J. (2025). Affibody-based HER2 prodrug shows conditional cytotoxic effect on HER2-positive cancer cells. Biochemical and Biophysical Research Communications - BBRC, 758.
[46]
Villanueva Raisman, A., Kotol, D., Altay, Ö., Mardinoglu, A., Atak, D., Yurdaydin, C. ... Edfors, F. (2025). Advancing Chronic Liver Disease Diagnoses: Targeted Proteomics for the Non-Invasive Detection of Fibrosis. Livers, 5(1).
[47]
Alanko, V., Mravinacová, S., Hall, A., Hagman, G., Mohanty, R., Westman, E. ... Matton, A. (2025). Biological signatures in the Alzheimer's continuum discriminate between diagnosis-related and -unrelated associations to ATN categories. Brain Communications, 7(2).
[48]
Teworte, S., Behrens, M. C., Widhe, M., Gurzeler, L.-A., Hedhammar, M. & Luciani, P. (2025). A Fibronectin (FN)-Silk 3D Cell Culture Model as a Screening Tool for Repurposed Antifibrotic Drug Candidates for Endometriosis. Small.
[49]
Soleimani, S., Albayrak, O., Somay, K., Yang, H., Yigit, B., Ulukan, B. ... Zeybel, M. (2025). Cellular and immune landscape of chronic liver diseases : insights from immunophenotyping. Frontiers in Molecular Biosciences, 11.
[50]
Mravinacová, S., Bergström, S., Olofsson, J., de San José, N. G., Anderl-Straub, S., Diehl-Schmid, J. ... Månberg, A. (2025). Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases. Scientific Reports, 15(1).